BACKGROUND: Identification of novel cancer-causing genes is one of the main goals in cancer research. The rapid accumulation of genome-wide protein-protein interaction (PPI) data in humans has provided a new basis for studying the topological features of cancer genes in cellular networks. It is important to integrate multiple genomic data sources, including PPI networks, protein domains and Gene Ontology (GO) annotations, to facilitate the identification of cancer genes. METHODS: Topological features of the PPI network, as well as protein domain compositions, enrichment of gene ontology categories, sequence and evolutionary conservation features were extracted and compared between cancer genes and other genes. The predictive power of various classifiers for identification of cancer genes was evaluated by cross validation. Experimental validation of a subset of the prediction results was conducted using siRNA knockdown and viability assays in human colon cancer cell line DLD-1. RESULTS: Cross validation demonstrated advantageous performance of classifiers based on support vector machines (SVMs) with the inclusion of the topological features from the PPI network, protein domain compositions and GO annotations. We then applied the trained SVM classifier to human genes to prioritize putative cancer genes. siRNA knock-down of several SVM predicted cancer genes displayed greatly reduced cell viability in human colon cancer cell line DLD-1. CONCLUSION: Topological features of PPI networks, protein domain compositions and GO annotations are good predictors of cancer genes. The SVM classifier integrates multiple features and as such is useful for prioritizing candidate cancer genes for experimental validations.
BACKGROUND: Identification of novel cancer-causing genes is one of the main goals in cancer research. The rapid accumulation of genome-wide protein-protein interaction (PPI) data in humans has provided a new basis for studying the topological features of cancer genes in cellular networks. It is important to integrate multiple genomic data sources, including PPI networks, protein domains and Gene Ontology (GO) annotations, to facilitate the identification of cancer genes. METHODS: Topological features of the PPI network, as well as protein domain compositions, enrichment of gene ontology categories, sequence and evolutionary conservation features were extracted and compared between cancer genes and other genes. The predictive power of various classifiers for identification of cancer genes was evaluated by cross validation. Experimental validation of a subset of the prediction results was conducted using siRNA knockdown and viability assays in humancolon cancer cell line DLD-1. RESULTS: Cross validation demonstrated advantageous performance of classifiers based on support vector machines (SVMs) with the inclusion of the topological features from the PPI network, protein domain compositions and GO annotations. We then applied the trained SVM classifier to human genes to prioritize putative cancer genes. siRNA knock-down of several SVM predicted cancer genes displayed greatly reduced cell viability in humancolon cancer cell line DLD-1. CONCLUSION: Topological features of PPI networks, protein domain compositions and GO annotations are good predictors of cancer genes. The SVM classifier integrates multiple features and as such is useful for prioritizing candidate cancer genes for experimental validations.
Authors: M A Harris; J Clark; A Ireland; J Lomax; M Ashburner; R Foulger; K Eilbeck; S Lewis; B Marshall; C Mungall; J Richter; G M Rubin; J A Blake; C Bult; M Dolan; H Drabkin; J T Eppig; D P Hill; L Ni; M Ringwald; R Balakrishnan; J M Cherry; K R Christie; M C Costanzo; S S Dwight; S Engel; D G Fisk; J E Hirschman; E L Hong; R S Nash; A Sethuraman; C L Theesfeld; D Botstein; K Dolinski; B Feierbach; T Berardini; S Mundodi; S Y Rhee; R Apweiler; D Barrell; E Camon; E Dimmer; V Lee; R Chisholm; P Gaudet; W Kibbe; R Kishore; E M Schwarz; P Sternberg; M Gwinn; L Hannick; J Wortman; M Berriman; V Wood; N de la Cruz; P Tonellato; P Jaiswal; T Seigfried; R White Journal: Nucleic Acids Res Date: 2004-01-01 Impact factor: 16.971
Authors: Suraj Peri; J Daniel Navarro; Troels Z Kristiansen; Ramars Amanchy; Vineeth Surendranath; Babylakshmi Muthusamy; T K B Gandhi; K N Chandrika; Nandan Deshpande; Shubha Suresh; B P Rashmi; K Shanker; N Padma; Vidya Niranjan; H C Harsha; Naveen Talreja; B M Vrushabendra; M A Ramya; A J Yatish; Mary Joy; H N Shivashankar; M P Kavitha; Minal Menezes; Dipanwita Roy Choudhury; Neelanjana Ghosh; R Saravana; Sreenath Chandran; Sujatha Mohan; Chandra Kiran Jonnalagadda; C K Prasad; Chandan Kumar-Sinha; Krishna S Deshpande; Akhilesh Pandey Journal: Nucleic Acids Res Date: 2004-01-01 Impact factor: 16.971
Authors: P Andrew Futreal; Lachlan Coin; Mhairi Marshall; Thomas Down; Timothy Hubbard; Richard Wooster; Nazneen Rahman; Michael R Stratton Journal: Nat Rev Cancer Date: 2004-03 Impact factor: 60.716
Authors: Yan Kou; Catalina Betancur; Huilei Xu; Joseph D Buxbaum; Avi Ma'ayan Journal: Am J Med Genet C Semin Med Genet Date: 2012-04-12 Impact factor: 3.908
Authors: Jian He; Han Bin Wang; Jiang Ju Huang; Lei Zhang; Dong Lin Li; Wan You He; Qing Ming Xiong; Zai Sheng Qin Journal: Exp Ther Med Date: 2021-05-18 Impact factor: 2.751